NCT02734901

Brief Summary

Accumulating evidence from epidemiological and human intervention studies indicates that the cardiovascular health benefits of diets rich in fruits and vegetables are (in part) related to their (poly)phenol content. Raspberries are rich in phenolic and polyphenolic compounds, in particular procyanidins, ellagitannins and anthocyanins, but also phenolic acids. At present, a small number of randomized controlled trials investigating the effects of berry (poly)phenols on validated surrogate markers of cardiovascular disease risk have shown promising results. However, to date, very few human studies have specifically investigated the effects of raspberry (poly)phenols on cardiovascular function in healthy subjects. Moreover, ellagitannin-derived metabolites are believed to persist for a long period of time in the blood and urine. Therefore, the investigators will investigate the presence of plasma and urinary raspberry-derived metabolites 24h post-consumption. To the investigators knowledge, the effects of red raspberry consumption on vascular function in humans have not been investigated before. This information is necessary for the planning of long-term studies aiming to assess the potential beneficial effects of raspberries,. Therefore, this study aims to investigate the potential role of red raspberry (poly)phenols in the modulation of vascular function by monitoring changes in vascular function together with the major (poly)phenol derivatives/metabolites in plasma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 12, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

October 20, 2016

Status Verified

October 1, 2016

Enrollment Period

6 months

First QC Date

March 9, 2016

Last Update Submit

October 19, 2016

Conditions

Keywords

polyphenolsvascular functionendothelial functionraspberry

Outcome Measures

Primary Outcomes (1)

  • Change from baseline to 2 hour and 24 hour in Endothelial function

    measured by flow mediated dilation (FMD) on baseline at 2 and 24 hour postconsumption

    Baseline, 2 hour and 24 hour

Secondary Outcomes (4)

  • Change from baseline to 2 hour and 24 hour in Pulse wave velocity

    Baseline, 2 hour and 24 hour

  • Change from baseline to 2 hour and 24 hour in Central blood pressure

    Baseline, 2 hour and 24 hour

  • Peripheral blood pressure

    Baseline, 2 h and 24 h

  • Change from baseline to 2 hour and 24 hour in Heart rate

    Baseline, 2 hour and 24 hour

Other Outcomes (2)

  • Change from baseline to 2 hour and 24 hour in Polyphenol metabolites in blood plasma

    Baseline, 2 hour and 24 hour

  • Change from baseline to 2 hour and 24 hour in Polyphenol metabolites in urine

    Baseline, 2 hour and 24 hour

Study Arms (3)

400 g frozen raspberries

ACTIVE COMPARATOR

Red raspberry beverage Acute intake of 600 mL (1x daily)

Dietary Supplement: 400 g frozen raspberries

200 g frozen raspberries

ACTIVE COMPARATOR

Red raspberry beverage Acute intake of 600 mL (1x daily)

Dietary Supplement: 200 g frozen raspberries

Placebo control

PLACEBO COMPARATOR

Raspberry deprived supplement Acute intake of 600 mL (1x daily)

Dietary Supplement: Placebo

Interventions

400 g frozen raspberriesDIETARY_SUPPLEMENT

1x daily intake of 600 mL red raspberry beverage

400 g frozen raspberries
200 g frozen raspberriesDIETARY_SUPPLEMENT

1x daily intake of 600 mL red raspberry beverage

200 g frozen raspberries
PlaceboDIETARY_SUPPLEMENT

1x daily intake of 600 mL raspberry deprived supplement

Placebo control

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy male subjects (no clinical signs or symptoms of cardiovascular disease)

You may not qualify if:

  • Cardiovascular disease
  • acute inflammation
  • cardiac arrhythmia
  • renal failure
  • heart failure (NYHA II-IV)
  • diabetes mellitus
  • C - reactive protein \> 05 mg/dL
  • malignant disease
  • raspberry allergy/intolerance
  • hypotension (≤100 / 60 mm Hg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf

Düsseldorf, 40225, Germany

Location

Related Publications (1)

  • Istas G, Feliciano RP, Weber T, Garcia-Villalba R, Tomas-Barberan F, Heiss C, Rodriguez-Mateos A. Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: A double-blind randomized controlled trial. Arch Biochem Biophys. 2018 Aug 1;651:43-51. doi: 10.1016/j.abb.2018.05.016. Epub 2018 May 24.

Study Officials

  • Ana Rodriguez-Mateos, PhD

    Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf

    PRINCIPAL INVESTIGATOR
  • Christian Heiss, MD

    Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2016

First Posted

April 12, 2016

Study Start

March 1, 2016

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

October 20, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations